COMPOSITION COMPRISING IL-1RA AS INTERLEUKIN-1 INHIBITOR AND HYALURONAN AS CONTROLLED RELEASE POLYMER

摘要

A pharmaceutical composition comprising (a) an effective amount of controlled release polymer and (b) an effective amount of a IL-1ra. The composition exhibits a therapeutic effect on inflammation and is useful for treating IL-1 mediated inflammatory diseases, particularly diseases of the joint.